May 12, 2024

Revolutionizing Medicine: DoseMeRx's Journey to Smarter Dosing!

Paul Edwards is the President and CEO of DoseMeRx. He has been a Senior Executive with Merck and GSK, and start-ups including ILUM Health Solutions, Infectious Disease Connect, and TrackMy Solutions. He has an extensive history in infectious disease,...

Paul Edwards is the President and CEO of DoseMeRx. He has been a Senior Executive with Merck and GSK, and start-ups including ILUM Health Solutions, Infectious Disease Connect, and TrackMy Solutions. He has an extensive history in infectious disease, antimicrobial stewardship, and precision medicine.

 

  • Guest Introduction: Paul Edwards, the President and CEO of DoseMeRx, shares his extensive background in the pharmaceutical industry, including roles at Merck, GSK, and various startups, focusing on antibiotics and infectious diseases.

  • Pharmaceutical Journey: Paul discusses his career progression from selling macrolides to leading infectious disease units and moving to the U.S. to transform commercial models at Merck, emphasizing the importance of real-world data over clinical trial data.

  • DoseMeRx Focus: DoseMeRx specializes in precise dosing for critically ill patients using therapeutic drug monitoring, particularly for injectable antibiotics, aiming to provide accurate dosing information through web-based and integrated models within hospital systems.

  • Challenges and Future of Medicine: Paul highlights the importance of antimicrobial stewardship, pharmacogenomics, and personalized medicine in improving patient care and expresses concerns about the current insurance and payment systems based on actuarial science.

Please check out our Life Science Success Resources.  You will find tools that will support growing companies and books for authors I have interviewed.  

Paul Edwards Profile Photo

Paul Edwards

President & CEO

Paul has been a Senior Executive with Merck and GSK, and start-ups including ILUM Health Solutions, Infectious Disease Connect, and TrackMy Solutions. He has an extensive history in infectious disease, antimicrobial stewardship, and precision medicine. He has led strategic and operational teams that have implemented antimicrobial stewardship programs in many countries around the world, most notably the United States, United Kingdom, India, South Africa, and Colombia. It is with this global perspective that Paul understands the critical importance of how Bayesian dosing software can have a significant impact on both patient and hospital outcomes. Paul holds an MBA from Oxford Brookes University in the UK. He lives in Jupiter, Florida with his wife Dianne.

New to the podcast?

Aug. 11, 2023

Thomas Farb-Horch - CEO of Thrive Bio

This week on the Life Science Success podcast, my guest is Thomas Farb-Horch. Thomas is the CEO of Thrive Bio. He has been involved in the founding of 18 pharmaceutical, biotech, medtech, software, and AI companies, 7 of which have …

Listen to the Episode
Nov. 18, 2023

Cristian Massacesi - Chief Medical Officer & Oncology Chief Developme…

In this episode of Life Science Success, my guest is Cristian Massacesi MD. Cristian is the Chief Medical Officer & Oncology Chief Development Officer at AstraZeneca. In the interview, we will discuss his start in oncology, his career...

Listen to the Episode
March 17, 2024

The Power of GenAI in Life Sciences - Elizabeth Smalley ArisGlobal

This week on Life Science Success, we are thrilled to welcome back Elizabeth Smalley as our guest. Elizabeth is the VP, Product Management, Data & Analytics at ArisGlobal, where she plays a pivotal role in steering the company’s strategic...

Listen to the Episode
April 6, 2024

Dr. Mohit Jain Unveils Next-Gen Tech in Drug Discovery & Therapy

In this episode of Life Science Success, host Don Davis has a conversation with Dr. Mohit Jain, a physician scientist with extensive experience in physiology, biomedicine, and mass spectrometry. Dr. Jain shares his unique journey from clinical...

Listen to the Episode
May 25, 2024

Christiaan Engstrom CEO Bullpen & Bio 2024 Events

In this episode of the Life Science Success Podcast, host Don Davis interviews Christian Engstrom, CEO of Bullpen, an elite club focused on fostering collaborative success in the life sciences industry. They discuss Christian's background, his...

Listen to the Episode
June 29, 2024

Unlocking Precision Cancer Care with Tushar Pandey CEO Symbiosys

Tushar Pandey is a distinguished expert in the Life Sciences industry, currently making significant strides at SimBioSys with his innovative approach to healthcare technology. His contributions have been pivotal in advancing medical solutions and...

Listen to the Episode
June 29, 2024

How William Hind's Belief Continuum is Revolutionizing Pharma Communi…

In this episode of Life Science Success, my guest is William Hind. William, the founder of Alpharmaxim, is transforming how pharma companies communicate their value to healthcare providers. In this episode of Life Science Success, host Don interviews...

Listen to the Episode